BFRI 1 (-3.85%)
US09077D1000Drug ManufacturersDrug Manufacturers - Specialty & Generic

Biofrontera (BFRI) Competitor Comparison

We are evaluating the key criteria listed to compare Biofrontera (BFRI) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 5 years - BFRI ranking 43 / 54

These are the competitors of Biofrontera in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 5 years
1. Kamada KMDA
30.27
2. Catalent CTLT
24.83
3. Supernus Pharmaceuticals SUPN
15.5
4. ANI Pharmaceuticals ANIP
14.76
5. Alimera Sciences ALIM
11.43
6. Regencell Bioscience Holdings RGC
11.2
7. Amneal Pharmaceuticals AMRX
9.55
8. Pacira BioSciences PCRX
9.27
9. PetIQ PETQ
8.71
10. Neoleukin Therapeutics NLTX
8.58
11. Vifor Pharma G2AB.F
7.23
12. Alvotech ALVO
7.02
13. Relmada Therapeutics RLMD
6.34
14. Perrigo PRGO
6.27
15. Ironwood Pharmaceuticals IRWD
5.56
16. Evolus EOLS
5.5
17. ProPhase Labs PRPH
5.2
18. Green Thumb Industries R9U2.F
5.04
19. Kolinpharma KIP.MI
4.88
20. Curaleaf Holdings CURLF
4.75
21. Zoetis ZTS
4.46
22. Ayr Wellness 3KJB.F
4.4
23. Phibro Animal Health PAHC
4.34
24. Elanco Animal Health ELAN
4.04
25. Linc LNC
3.96
26. Organogenesis Holdings ORGO
3.88
27. Bausch Health Companies BHC
3.35
28. Taro Pharmaceutical Industries TARO
3.28
29. Emergent BioSolutions EBS
3.21
30. Procaps Group PROC
3.1
31. Eagle Pharmaceuticals EGRX
2.6
32. Embecta EMBC
2.49
33. Zynerba Pharmaceuticals ZYNE
2.47
34. Cumberland Pharmaceuticals CPIX
2.4
35. Jupiter Wellness JUPW
2.39
36. Journey Medical DERM
2.3
37. Societal CDMO SCTL
2.21
38. SCYNEXIS SCYX
2.2
39. Solid Biosciences SLDB
2.15
40. Theratechnologies THTX
2.01
41. Clever Leaves Holdings CLVR
1.97
42. OptiNose OPTN
1.83
43. Biofrontera BFRI
1.83
44. Cronos Group CRON
1.8
45. Flora Growth FLGC
1.79
46. Ascend Wellness Holdings AAWH
1.77
47. Alpha Teknova TKNO
1.74
48. Universe Pharmaceuticals UPC
1.68
49. Amphastar Pharmaceuticals AMPH
1.68
50. Teva Pharmaceutical Industries TEVA
1.62
51. Tilray Brands TLRY
1.6
52. Collegium Pharmaceutical COLL
0.97
53. Harrow Health HROW
0.66
54. Avadel Pharmaceuticals AVDL
0.42

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.